Cargando…
What and how should we measure in paediatric oncology FDG-PET/CT? Comparison of commonly used SUV metrics for differentiation between paediatric tumours
BACKGROUND: In clinical routine, SUV(max) and SUV(peak) are most often used to determine the glucose metabolism in tumours by (18)F-FDG PET/CT. Both metrics can be further normalised to SUVs in reference regions resulting in a SUV ratio (SUV(ratio)). The aim of the study was to directly compare seve...
Autores principales: | Blautzik, Janusch, Grelich, Leonie, Schramm, Nicolai, Henkel, Rebecca, Bartenstein, Peter, Pfluger, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928180/ https://www.ncbi.nlm.nih.gov/pubmed/31872312 http://dx.doi.org/10.1186/s13550-019-0577-7 |
Ejemplares similares
-
The Impact of PET/CT on Paediatric Oncology
por: Brink, Anita, et al.
Publicado: (2023) -
Interobserver variability of image-derived arterial blood SUV in whole-body FDG PET
por: Hofheinz, Frank, et al.
Publicado: (2019) -
FDG Dose Extravasations in PET/CT: Frequency and Impact on SUV Measurements
por: Osman, Medhat M., et al.
Publicado: (2011) -
A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
por: Nikulin, Pavel, et al.
Publicado: (2020) -
FDG-PET staging and importance of lymph node SUV in head and neck cancer
por: Kubicek, Gregory J, et al.
Publicado: (2010)